LivRelief Osteo
Natural health product licensed in Canada
- Licence holder
- Delivra Inc.
- NPN or DIN-HM
- 80087504
- Status
- Active licence
- Licence date
- 31 July 2018
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Phytosterols Source : Huile de graine | 1.05 % |
| 3,3',4',5,7-Pentahydroxyflavone-3-rutinoside Source : Ruta graveolens - plante entière | 0.75 % |
Non-medicinal ingredients
Palmitate de cétyle, Glycérine, Acide benzoïque, Olivate de sorbitan, Sodium Stearoyl Lactylate, Ethoxydiglycol, Dimethyl isosorbide, Extrait de fleur de Sambucus nigra, Cire de Carnauba, Acide Déshydroacétique, Palmitate de sorbitan, sodium phytate, Aqua, Méthylsulfonylméthane, citrate de sodium, Gomme de xanthane, Caprylate Propylheptylique, Huile de pépin de cassis, Cetearyl olivate, Ethylhexylglycérine, Phénoxyéthanol, Extrait de péricarpe de punica granatum, Huile de graine de Rubus idaeus (Framboise)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 mL ; maximum: 1.5 mL | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve pain and/or inflammation in muscle and joints (e.g. sprains, bruises, joint pain)
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80087504
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.